Skip to main content

Table 1 Current tenofovir PREP Studies

From: Media reporting of tenofovir trials in Cambodia and Cameroon

Study Location

Population Group

Sponsor

Study Goal

Expected Initial Results

Cambodia

Commercial sex workers 960 volunteers

NIH

Safety & efficacy

2007

Cameroon, Ghana

High-risk women 800 volunteers

FHI

Safety & efficacy

2007

Malawi

High-risk men 500 volunteers

FHI

Safety & efficacy

2007

Botswana

Young adults 1,200 volunteers

CDC

Safety &efficacy

2007

Thailand

Injection drug users 1,600 volunteers

CDC

Safety & efficacy

2007

United States

Men who have sex with men

CDC

Safety

2007

Peru

Men who have sex with men 2,100 volunteers

NIH

Safety & efficacy

2008